Articles
Global elimination: securing a future free from cervical cancer
August 7th 2020, much of the world was in various states of lockdown, anxiously awaiting news about progress in development of vaccines against the new SARS-Cov-2 virus, which by then had taken the lives of almost 1 million people. But…
Do patents encourage or discourage innovation? Intellectual property from ancient Greece to the Covid pandemic
In October 2020, India and South Africa submitted to the World Trade Organization (WTO) a proposal for a waiver from certain provisions of the Trips agreement – the 1994 WTO Agreement on Trade-Related Aspects of Intellectual Property Rights. The rationale…
Molecular diagnostics and NGS in the clinic: where are we and where do we need to go?
The development of next generation sequencing (NGS) has been a game changer for our understanding of genetics, and in turn for many aspects of biomedicine. This includes cancer, where it has led to greater understanding of the genetic changes that…
The invisible cure. Should we be talking more about cancer surgery?
The best chance of being cured of cancer is through surgery by expert surgeons with a deep knowledge of oncology. Why then are the public, patients and policy makers so focused on drugs, and does it matter? Mass media have…
Precision care: supporting our patients starts with asking them what they want and need
Two weeks after receiving a brain tumour diagnosis, Martin was copied into an email from one of his healthcare team telling his GP that Martin was “understandably devastated by his diagnosis”. The words came as a shock. “My healthcare team…
On being a woman in oncology: in their own words
Over the past two decades, Cancer World has had the privilege of publishing profiles of many women who have been leading efforts to improve the quality of cancer care. Coming from all corners of Europe, working in all areas of…
Chemobrain: it’s real, it’s troublesome and it deserves more attention
Fiona Henderson was part way through her psychology degree when she received her breast cancer diagnosis. Right after treatments finished, she returned to her studies – initially without a problem. “Three or four months later, I really struggled. I was…
Beating the odds in colorectal cancer
Stefan Gijssels beat the odds in colorectal cancer. Diagnosed with a cancer of the colon in 2015, a laparoscopic surgery intended to remove what was thought to be a locally contained tumour revealed something much nastier. The cancer had pierced…
Lung cancer screening: 2022 could be a turning point for Europe
If cancer screening policies were driven purely by mortality rates and curability, then lung cancer would long have topped the priority list for population screening programmes. Accounting for almost one in every four cancer deaths in men and almost one…
Tackling drug resistance: how our commensal bacteria can hinder or help
Response to therapeutics can differ widely from patient to patient, with some gaining highly significant survival benefits from a therapy that in others elicits no response at all. Patients who respond initially often develop resistance or relapse over time. Not…